|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brundage MD, Davies D and Mackillop WJ:
Prognostic factors in non-small cell lung cancer: A decade of
progress. Chest. 122:1037–1057. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Choi PJ, Jeong SS and Yoon SS: Prediction
and prognostic factors of post-recurrence survival in recurred
patients with early-stage NSCLC who underwent complete resection. J
Thorac Dis. 8:152–160. 2016.PubMed/NCBI
|
|
4
|
Botling J, Edlund K, Lohr M, Hellwig B,
Holmberg L, Lambe M, Berglund A, Ekman S, Bergqvist M, Pontén F, et
al: Biomarker discovery in non-small cell lung cancer: Integrating
gene expression profiling, meta-analysis, and tissue microarray
validation. Clin Cancer Res. 19:194–204. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang X, Cao W, Zhang L, Zhang W, Zhang X
and Lin H: Targeting 14-3-3zeta in cancer therapy. Cancer Gene
Ther. 19:153–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
La Porta S, Roth L, Singhal M, Mogler C,
Spegg C, Schieb B, Qu X, Adams RH, Baldwin HS, Savant S and
Augustin HG: Endothelial Tie1-mediated angiogenesis and vascular
abnormalization promote tumor progression and metastasis. J Clin
Invest. 128:834–845. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Niemantsverdriet M, Wagner K, Visser M and
Backendorf C: Cellular functions of 14-3-3 zeta in apoptosis and
cell adhesion emphasize its oncogenic character. Oncogene.
27:1315–1319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu J, Guo H, Treekitkarnmongkol W, Li P,
Zhang J, Shi B, Ling C, Zhou X, Chen T, Chiao PJ, et al: 14-3-3zeta
Cooperates with ErbB2 to promote ductal carcinoma in situ
progression to invasive breast cancer by inducing
epithelial-mesenchymal transitition. Cancer Cell. 16:195–207. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen CH, Chuang SM, Yang MF, Liao JW, Yu
SL and Chen JJ: A novel function of YWHAZ/β-catenin axis in
promoting epithelial-mesenchymal transition and lung cancer
metastasis. Mol Cancer Res. 10:1319–1331. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Z, Zhao J, Du Y, Park HR, Sun SY,
Bernal-Mizrachi L, Aitken A, Khuri FR and Fu H: Down-regulation of
14-3-3zeta suppresses anchorage-independent growth of lung cancer
cells through anoikis activation. Proc Natl Acad Sci USA.
105:162–167. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Neal CL, Yao J, Yang W, Zhou X, Nguyen NT,
Lu J, Danes CG, Guo H, Lan KH, Ensor J, et al: 14-3-3zeta
overexpression defines high risk for breast cancer recurrence and
promotes cancer cell survival. Cancer Res. 69:3425–3432. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Choi JE, Hur W, Jung CK, Piao LS, Lyoo K,
Hong SW, Kim SW, Yoon HY and Yoon SK: Silencing of 14-3-3ζ
over-expression in hepatocellular carcinoma inhibits tumor growth
and enhances chemosensitivity to cis-diammined dichloridoplatium.
Cancer Lett. 303:99–107. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao W, Yang X, Zhou J, Teng Z, Cao L,
Zhang X and Fei Z: Targeting 14-3-3 protein, difopein induces
apoptosis of human glioma cells and suppresses tumor growth in
mice. Apoptosis. 15:230–241. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Clark GJ, Drugan JK, Rossman KL, Carpenter
JW, Rogers-Graham K, Fu H, Der CJ and Campbell SL: 14-3-3 zeta
negatively regulates raf-1 activity by interactions with the Raf-1
cysteine-rich domain. J Biol Chem. 272:20990–20993. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li FQ, Mofunanya A, Harris K and Takemaru
K: Chibby cooperates with 14-3-3 to regulate beta-catenin
subcellular distribution and signaling activity. J Cell Biol.
181:1141–1154. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu Pc, Sun Y, Xu R, Sang Y, Zhao J, Liu
G, Cai L, Li C and Zhao S: The interaction between ADAM 22 and
14-3-3zeta: Regulation of cell adhesion and spreading. Biochem
Biophys Res Commun. 301:991–999. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Daugaard I, Sanders KJ, Idica A,
Vittayarukskul K, Hamdorf M, Krog JD, Chow R, Jury D, Hansen LL,
Hager H, et al: miR-151a induces partial EMT by regulating
E-cadherin in NSCLC cells. Oncogenesis. 6:e3662017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li S, Xu F, Zhang J, Wang L, Zheng Y, Wu
X, Wang J, Huang Q and Lai M: Tumor-associated macrophages
remodeling EMT and predicting survival in colorectal carcinoma.
Oncoimmunology. 7:e13807652017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Peinado H, Portillo F and Cano A:
Transcriptional regulation of cadherins during development and
carcinogenesis. Int J Dev Biol. 48:365–375. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Taddei ML, Chiarugi P, Cirri P, Buricchi
F, Fiaschi T, Giannoni E, Talini D, Cozzi G, Formigli L, Raugei G
and Ramponi G: Beta-catenin interacts with low-molecular-weight
protein tyrosine phosphatase leading to cadherin-mediated cell-cell
adhesion increase. Cancer Res. 62:6489–6499. 2002.PubMed/NCBI
|
|
21
|
Chen JJ, Peck K, Hong TM, Yang SC, Sher
YP, Shih JY, Wu R, Cheng JL, Roffler SR, Wu CW and Yang PC: Global
analysis of gene expression in invasion by a lung cancer model.
Cancer Res. 61:5223–5230. 2001.PubMed/NCBI
|
|
22
|
Guo Y, Yin J, Zha L and Wang Z:
Clinicopathological significance of platelet-derived growth factor
B, platelet-derived growth factor receptor-β and E-cadherin
expression in gastric carcinoma. Contemp Oncol (Pozn). 17:150–155.
2013.PubMed/NCBI
|
|
23
|
Chassagnon G, Bennani S and Revel MP: New
TNM classification of non-small cell lung cancer. Rev Pneumol Clin.
73:34–39. 2017.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Harms A, Kriegsmann M, Fink L, Länger F
and Warth A: The new TNM classification for lung tumors: Changes
and the assessment of multiple tumor foci. Pathologe. 38:11–20.
2017.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tang D, Xu S, Zhang Q and Zhao W: The
expression and clinical significance of the androgen receptor and
E-cadherin in triple-negative breast cancer. Med Oncol. 29:526–533.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao L, Antic T, Hyjek E, Gong C, Mueller
J, Waxman I, DeMay RM and Reeves W: Immunohistochemical analysis of
E-cadherin and zeste homolog 2 expression in endoscopic
ultrasound-guided fine-needle aspiration of pancreatic
adenocarinoma. Cancer Cytopathol. 121:644–652. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Elzagheid A, Buhmeida A, Laato M,
El-Faitori O, Syrjänen K, Collan Y and Pyrhönen S: Loss of
E-cadherin expression predicts disease recurrence and shorter
survival in colorectal carcinoma. APMIS. 120:539–548. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhai B, Yan HX, Liu SQ, Chen L, Wu MC and
Wang HY: Reduced expression of E-cadherin/catenin complex in
hepatocellular carcinomas. World J Gastroenterol. 14:5665–5673.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ling C, Raasch JL and Welham NV:
E-cadherin and transglutaminase-1 epithelial barrier restoration
precedes type IV collagen basement membrane reconstruction
following vocal fold mucosal injury. Cells Tissues Organs.
193:158–169. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Molina-Ortiz I, Bartolomé RA,
Hernández-Varas P, Colo GP and Teixidó J: Overexpression of
E-cadherin on melanoma cells inhibits chemokine-promoted invasion
involving p190RhoGAP/p120ctn-dependent inactivation of RhoA. J Biol
Chem. 284:15147–15157. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Larriba MJ, Casado-Vela J, Pendás-Franco
N, Peña R, de Herreros García A, Berciano MT, Lafarga M, Casal JI
and Muñoz A: Novel snail1 target proteins in human colon cancer
identified by proteomic analysis. PLoS One. 5:e102212010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tong S, Xia T, Fan K, Jiang K, Zhai W, Li
JS, Wang SH and Wang JJ: 14-3-3ζ promotes lung cancer cell invasion
by increasing the Snail protein expression through atypical protein
kinase C (aPKC)/NF-κB signaling. Exp Cell Res. 348:1–9. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Campbell PM and Der CJ: Oncogenic Ras and
its role in tumor cell invasion and metastasis. Semin Cancer Biol.
14:105–114. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee JY, Lowell CA, Lemay DG, Youn HS, Rhee
SH, Sohn KH, Jang B, Ye J, Chung JH and Hwang DH: The regulation of
the expression of inducible nitric oxide synthase by Src-family
tyrosine kinases mediated through MyD88-independent signaling
pathways of Toll-like receptor 4. Biochem Pharmacol. 70:1231–1240.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pautz A, Art J, Hahn S, Nowag S, Voss C
and Kleinert H: Regulation of the expression of inducible nitric
oxide synthase. Nitric Oxide. 23:75–93. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hollestelle A, Peeters JK, Smid M,
Timmermans M, Verhoog LC, Westenend PJ, Heine AA, Chan A, Sieuwerts
AM, Wiemer EA, et al: Loss of E-cadherin is not a necessity for
epithelial to mesenchymal transition in human breast cancer. Breast
Cancer Res Treat. 138:47–57. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen A, Beetham H, Black MA, Priya R,
Telford BJ, Guest J, Wiggins GA, Godwin TD, Yap AS and Guilford PJ:
E-cadherin loss alters cytoskeletal organization and adhesion in
non-malignant breast cells but is insufficient to induce an
epithelial-mesenchymal transition. BMC Cancer. 14:5522014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ahn SM, Cha JY, Kim J, Kim D, Trang HT,
Kim YM, Cho YH, Park D and Hong S: Smad3 regulates E-cadherin via
miRNA-200 pathway. Oncogene. 31:3051–3059. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mise N, Savai R, Yu H, Schwarz J, Kaminski
N and Eickelberg O: Zyxin is a transforming growth factor-β
(TGF-β)/Smad3 target gene that regulates lung cancer cell motility
via integrin α5β1. J Biol Chem. 287:31393–31405. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhao GY, Ding JY, Lu CL, Lin ZW and Guo J:
The overexpression of 14-3-3ζ and Hsp27 promotes non–small cell
lung cancer progression. Cancer. 120:652–663. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen HH, Wang Y, Xu YJ, Du ZY, Hao HJ, Xu
DY, Tan XG, Lin HY and Lu YL: Inhibition of metastasis of lung
cancer cells by 14-3-3ζ protein:an experimental investigation. Bull
Acad Milit. 2005.
|
|
42
|
An N, Zhu W, Feng Z, Ye S, Yu C and Cai C:
Effect of 20(R) ginsenoside Rg3 on protein expression of lung
cancer cell line. Zhongguo Fei Ai Za Zhi. 11:311–320. 2008.(In
Chinese). PubMed/NCBI
|
|
43
|
Schneider BJ and Kalemkerian GP:
Personalized therapy of small cell lung cancer. Adv Exp Med Biol.
890:149–174. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhu P, Sang Y, Xu H, Zhao J, Xu R, Sun Y,
Xu T, Wang X, Chen L, Feng H, et al: ADAM22 plays an important role
in cell adhesion and spreading with the assistance of 14-3-3.
Biochem Biophys Res Commun. 331:938–946. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kobayashi R, Deavers M, Patenia R,
Rice-Stitt T, Halbe J, Gallardo S and Freedman RS: 14-3-3 zeta
protein secreted by tumor associated monocytes/macrophages from
ascites of epithelial ovarian cancer patients. Cancer Immunol
Immunother. 58:247–258. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fan T, Li R, Todd NW, Qiu Q, Fang HB, Wang
H, Shen J, Zhao RY, Caraway NP, Katz RL, et al: Up-regulation of
14-3-3zeta in lung cancer and its implication as prognostic and
therapeutic target. Cancer Res. 67:7901–7906. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Khorrami A, Bagheri Sharif M, Tavallaei M
and Gharechahi J: The functional significance of 14-3-3 proteins in
cancer: Focus on lung cancer. Horm Mol Biol Clin Investig. 32:pii:
/j/hmbci.2017.32.issue-3/hmbci-2017-0032/hmbci-2017-0032.xml.
2017.PubMed/NCBI
|
|
48
|
Cau Y, Valensin D, Mori M, Draghi S and
Botta M: Structure, function, involvement in diseases and targeting
of 14-3-3 proteins: An update. Curr Med Chem. 25:5–21. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ko S, Kim JY, Jeong J, Lee JE, Yang WI and
Jung WH: The role and regulatory mechanism of 14-3-3 sigma in human
breast cancer. J Breast Cancer. 17:207–218. 2014. View Article : Google Scholar : PubMed/NCBI
|
